Status:
COMPLETED
A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA
Lead Sponsor:
Pfizer
Conditions:
Arthritis, Juvenile Rheumatoid
Eligibility:
All Genders
2-18 years
Phase:
PHASE3
Brief Summary
To study Celebrex versus naproxen to see if it decreases symptoms of juvenile arthritis such as pain and swelling.
Eligibility Criteria
Inclusion
- 2-18 years old with active JRA
Exclusion
- other experimental meds, recent changes in arthritis meds
Key Trial Info
Start Date :
October 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2005
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT00652925
Start Date
October 1 2002
End Date
April 1 2005
Last Update
May 30 2008
Active Locations (58)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
San Diego, California, United States, 92123
2
Pfizer Investigational Site
Hartford, Connecticut, United States, 06106
3
Pfizer Investigational Site
Delray Beach, Florida, United States, 33484
4
Pfizer Investigational Site
Miami, Florida, United States, 33155